BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Belli C, Cereda S, Reni M. Role of taxanes in pancreatic cancer. World J Gastroenterol 2012; 18(33): 4457-4465 [PMID: 22969215 DOI: 10.3748/wjg.v18.i33.4457]
URL: https://www.wjgnet.com/1007-9327/full/v18/i33/4457.htm
Number Citing Articles
1
Morena Fasano, Carminia Maria Della Corte, Giovanni Vicidomini, Valerio Scotti, Pier Francesco Rambaldi, Alfonso Fiorelli, Marina Accardo, Ferdinando De Vita, Mario Santini, Fortunato Ciardiello, Floriana Morgillo. Small bowel metastasis from pancreatic cancer in a long-term survival patient with synchronous advanced malignant pleural mesothelioma: A case report and literature reviewOncology Letters 2016; 12(6): 4505 doi: 10.3892/ol.2016.5279
2
Yang Zhou, Yunjiang Zhou, Keke Wang, Tao Li, Minda Zhang, Yunjia Yang, Rui Wang, Rong Hu. ROCK2 Confers Acquired Gemcitabine Resistance in Pancreatic Cancer Cells by Upregulating Transcription Factor ZEB1Cancers 2019; 11(12): 1881 doi: 10.3390/cancers11121881
3
Gebremariam Birhanu, Hamid Akbari Javar, Ehsan Seyedjafari, Ali Zandi-Karimi. Nanotechnology for delivery of gemcitabine to treat pancreatic cancerBiomedicine & Pharmacotherapy 2017; 88: 635 doi: 10.1016/j.biopha.2017.01.071
4
Cindy Neuzillet, Annemilaï Tijeras-Raballand, Jérôme Cros, Sandrine Faivre, Pascal Hammel, Eric Raymond. Stromal expression of SPARC in pancreatic adenocarcinomaCancer and Metastasis Reviews 2013; 32(3-4): 585 doi: 10.1007/s10555-013-9439-3
5
Katsuhiko Mitachi, Rita G. Kansal, Kirk E. Hevener, Cody D. Gillman, Syed M. Hussain, Hyun Gi Yun, Gustavo A. Miranda-Carboni, Evan S. Glazer, William M. Clemons, Michio Kurosu. DPAGT1 Inhibitors of Capuramycin Analogues and Their Antimigratory Activities of Solid TumorsJournal of Medicinal Chemistry 2020; 63(19): 10855 doi: 10.1021/acs.jmedchem.0c00545
6
Saroj Majumdar, Dillip Muduly, Subhasis Mishra, Chinmaya Mohapatra, Deepak Bunger, Mujtaba Khan. Management of primary squamous cell carcinoma of the pancreas with a nanosomal paclitaxel lipid suspension-based regimen: A case reportMolecular and Clinical Oncology 2019;  doi: 10.3892/mco.2019.1814